Search

Search Constraints

You searched for: Author/Creator Aasebø, Elise

Search Results

1. How should quality of life assessment be integrated in the evaluation of patients with acute myeloid leukemia?. Issue 5 (2nd September 2016)

2. Label‐free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Issue 7 (April 2016)

3. Performance of super‐SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines. Issue 17 (8th August 2014)

4. Quantitative proteomics suggests decrease in the secretogranin‐1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Issue 19 (8th September 2015)

5. Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients. Issue 1 (December 2016)

8. Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison. (3rd July 2018)